Results 111 to 120 of about 49,999 (280)

The application and efficacy of stent place for Budd-Chiari syndrome

Journal of Interventional Medicine, 2018
: Objective To evaluate the application value and efficacy on stent place for Budd-Chiari syndrome (BCS).Methods From January 1990 to May 2017, 2228 patients with BCS were admitted to our institution. The mean age was 43.3 years.
Maoheng Zu, Hao Xu, Yuming Gu, Qingqiao Zhang, Ning Wei, Wei Xu, Yanfeng Cui   +6 more
doaj   +1 more source

A new approach to planning in vitro and in vivo experiments for cardiovascular stents. (1) Fundamentals of design procedures [PDF]

, 2000
Copyright @ 2000 Pacini Editore SpAWhile the use of cardiovascular stents is internationally widespread re-stenosis remains a common problem. There are a number of different designs, and this project seeks for design improvements leading to a reduction ...
Atherton, MA, Collins, MW, Doorly, DJ
core  

Pharmacologic approaches against advanced glycation end products (ages) in diabetic cardiovascular disease [PDF]

, 2015
Advanced Glycation End-Products (AGEs) are signaling proteins associated to several vascular and neurological complications in diabetic and non-diabetic patients.
Avtaar Singh, Sanjeet Singh, Chello, Massimo, DI DOMENICO, Fabio, Nappi, Francesco, Nenna, Antonio, Spadaccio, Cristiano, Sutherland, Fraser W   +6 more
core   +2 more sources

Long‐term Outcomes of Intraductal Fully Covered Self‐Expandable Metal Stents for Anastomotic Biliary Strictures After Living Donor Liver Transplantation: Clinical and Economic Evaluation

DEN Open, Volume 6, Issue 1, April 2026.
In this single‐center retrospective study of anastomotic biliary strictures after living donor liver transplantation, intraductal fully covered self‐expandable metal stents (ID‐FCSEMSs) achieved durable stricture resolution with low restenosis. Compared with multiple plastic stents, ID‐FCSEMS were associated with fewer late biliary complications and a ...
Akane Shimakura, Eisuke Ozawa, Mizuki Kitagawa, Kosuke Takahashi, Masanori Fukushima, Ryu Sasaki, Masafumi Haraguchi, Satoshi Miuma, Akihiko Soyama, Susumu Eguchi, Hisamitsu Miyaaki   +10 more
wiley   +1 more source

Recoil following Wiktor stent implantation for restenotic lesions of coronary arteries [PDF]

, 1994
The purpose of this study was to determine acute recoil of the vessel wall immediately after Wiktor stent implantation in native coronary arteries of 77 consecutive patients and to assess whether there was compression or “late recoil” of the stent itself
Bertrand, M.E. (Michel), Es, G.A. (Gerrit Anne) van, Jaegere, P.P.T. (Peter) de, Kober, G., Marquis, J.F., Piessens, J., Rutsch, W.R. (Wolfgang), Serruys, P.W.J.C. (Patrick), Uebis, R., Valeix, B., Vrolicz, M. (M.), Wiegand, V.   +11 more
core   +1 more source

RF‐Shielding of Laser‐Cut Venous Stents: Calculations, Simulations, and Experiments

Magnetic Resonance in Medicine, Volume 95, Issue 4, Page 2331-2344, April 2026.
ABSTRACT Purpose To develop an analytical model of the RF‐shielding of laser‐cut venous stents for different orientations and stent geometries. Methods Laser‐cut venous stents are modeled as a grid composed of circular and rectangular loops. As these loops are orthogonal they shield different components of the transmit RF field.
Lisa Regler, Felix Spreter, Kian Tadjalli Mehr, Niklas Verloh, Klaus Düring, Wibke Uller, Michael Bock, Simon Reiss   +7 more
wiley   +1 more source

Application of underdamped Langevin dynamics simulations for the study of diffusion from a drug-eluting stent

, 2018
We use a one-dimensional two layer model with a semi-permeable membrane to study the diffusion of a therapeutic drug delivered from a drug-eluting stent (DES).
Farago, Oded, Regev, Shaked
core   +1 more source

Clinical Outcomes of Drug-Eluting Balloon for In-Stent Restenosis Based on the Number of Metallic Layers [PDF]

, 2018
Hiroto Yabushita, Hiroyoshi Kawamoto, Yusuke Fujino, Satoko Tahara, Takeo Horikoshi, Miho Tada, Tatsuya Amano, Hirokazu Onishi, Akihiro Nakajima, Takayuki Warisawa, Yûsuke Watanabe, Toru Yoshizaki, Satoru Mitomo, T. Sato, Toru Naganuma, Hisaaki Ishiguro, Naoyuki Kurita, Shotarou Nakamura, Koji Hozawa, Sunao Nakamura   +19 more
openalex   +1 more source

Angioscopic and histopathological findings of in-stent restenosis in external iliac artery [PDF]

, 2023
Kohei Ukita, Yasuyuki Egami, Masami Nishino   +2 more
openalex   +1 more source

CYP2C19 genotype testing for clopidogrel: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI‐PGx)

British Journal of Clinical Pharmacology, Volume 92, Issue 2, Page 329-347, February 2026.
Clopidogrel, an antiplatelet agent, is currently licensed in the United Kingdom for the prevention and treatment of atherothrombotic events in cerebrovascular disease, coronary artery disease and peripheral arterial disease. Clopidogrel requires metabolic activation by the cytochrome P450 enzyme CYP2C19 to be effective.
Cinzia Dello Russo, Iain Frater, Rebecca Kuruvilla, Stefanie Lip, Hannah O'Neill, Kerry Burke, Vicky Chaplin, Alexander S. F. Doney, Salim Elyas, Nicholas Greaves, Sophie Harding, David Hargroves, Judith Hayward, Dyfrig A. Hughes, Tom A. T. Hughes, Sree Kondapally, Patrick Mok, Aaron Peace, Imran Rafi, Simon Ray, Vicky Stinton, Luigi Venetucci, Munir Pirmohamed   +22 more
wiley   +1 more source